Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
ID: 357019Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)" aimed at fostering collaborative research partnerships between academic and industrial investigators to accelerate the development of innovative bioengineering tools and technologies. The program seeks to establish multidisciplinary teams that apply a quantitative bioengineering approach to address significant biomedical challenges, with a focus on creating robust solutions that can enhance life science understanding and medical practices within a 5-10 year timeframe. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, and for-profit entities, particularly those emphasizing diversity in research. Interested parties should note that the application deadline is September 7, 2027, and for further inquiries, they can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information page at https://grants.nih.gov/grants/guide/pa-files/PAR-24-325.html.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services announces a funding opportunity titled "Bioengineering Partnerships with Industry," aimed at accelerating the development and adoption of innovative bioengineering tools and technologies that address critical biomedical challenges. This program encourages collaborative partnerships between academic researchers and industry stakeholders to create multidisciplinary teams focused on engineering solutions with a clear timeline and measurable goals within a 5-10 year timeframe. Key eligible applicants include higher education institutions, nonprofits, and for-profit organizations, particularly those that emphasize diversity and inclusion in research. The program requires a Leadership Plan detailing the roles and contributions of each team member, especially the industrial partner. Applications will undergo rigorous peer review based on factors such as significance, innovation, approach, and the expertise of investigators. The anticipated funding supports cooperative agreements, with no specific budget limits, subject to project needs, and follows strict compliance with NIH policies. The initiative recognizes the essential role of industry in transforming technologies into robust solutions that meet the needs of the medical community and ultimately enhance patient care.
    Similar Opportunities
    Loading similar opportunities...